Patients with non-ABO red blood cell antibodies: transfusion best practices for professionals

Tuesday, December 10, 2019 Tricia Abe

When a patient who needs a red blood cell transfusion has unexpected red blood cell antibodies (non-ABO) in their blood, health-care providers have to make decisions about what kind of red blood cell units can be safely transfused. Finding the right match for the patient is crucial because in some cases, transfusing incompatible donor units — those with antigens that could react with the patient’s antibodies — can result in serious complications, including acute or delayed hemolytic transfusion reactions. When pregnant mothers have these unexpected antibodies, they may require specialized prenatal care because their fetus or newborn may be at risk for a potentially life-threatening disease called hemolytic disease of the newborn.

To support hospital transfusion services and health-care providers in making clinical decisions that optimize patient care and use of blood products, Canadian Blood Services published new serological best practices on its professional education website. Dr. Gwen Clarke, associate medical director of clinical services at Canadian Blood Services and clinical professor in the University of Alberta’s department of laboratory medicine and pathology, collaborated with resident physicians from the University of Alberta Hematological Pathology residency training program to develop the best practices. Included are recommendations for selecting donor red blood cell units and other guidance to ensure transfusion patients receive red blood cell units that are the best match for them while avoiding requests for antigen-matched units or additional testing when these are not required.

For more resources for health-care providers, including leading practices and clinical guidelines, visit Canadian Blood Services' professional education website

Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.


Related blog posts

Wednesday, September 20, 2017
Dr. Jeannie Callum

In this six-part series, Dr. Jeannie Callum, a hospital-based transfusion specialist, shares her real-life experience witnessing the impact of blood donation on patient lives. She provides some fascinating insight into blood transfusion, past and present, and emphasizes the need for male donors and why some donors may be safer for patients. Read the complete series here.

Monday, May 28, 2018
Jenny Ryan

On the surface of our red blood cells are proteins called antigens. There are more than 600 known antigens — and some combinations of antigens are far less common than others.

Thursday, February 22, 2018
Dr. Kendra Hodgkinson

Knowledge dissemination is a vital step needed for research to be translated into new applications and improved processes. Through our Centre for Innovation, Canadian Blood Services conducts and supports research related to transfusion medicine and hematopoietic stem cell transplantation. KnowledgeInfusion webinars disseminate our research findings to Canadian Blood Services staff, helping them learn about exciting new discoveries and understand how they can be applied to address the organization’s challenges. The presentations are also recorded and shared on our Professional Education website to reach a broader audience.